Prognostic factors and their importance in relapsed and refractory AML: Comments on "Additional impact of mutational genotype on prognostic determination in resistant and relapsed acute myeloid leukaemia" by Linch et al

Leuk Res. 2021 Jun:105:106572. doi: 10.1016/j.leukres.2021.106572. Epub 2021 Mar 30.
No abstract available

Publication types

  • Comment

MeSH terms

  • Cytarabine
  • Genotype
  • Humans
  • Leukemia, Myeloid, Acute* / drug therapy
  • Leukemia, Myeloid, Acute* / genetics
  • Neoplasm Recurrence, Local* / genetics
  • Prognosis

Substances

  • Cytarabine